Clinical trial
Protection During Carotid Stenting in High Risk Patients With the TriActiv ProGuard System
NCT00395785 is registered in ClinicalTrials.gov with Kensey Nash Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Protection During Carotid Stenting in High Risk Patients With the TriActiv ProGuard System
- Lead sponsor
- Kensey Nash Corporation
- Phase
- Phase 2/3
- Overall status
- Terminated
- Start date
- November 30, 2006
- Completion date
- June 30, 2007
- Enrollment
- 400 (estimated)
- Sites
- 34
Conditions
As the registry lists them; a condition with its own page is linked.